Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02667119 · ClinicalTrials.gov registry record · NA
Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02667119: Completed NA study, sponsored by UConn Health.
NCT02667119 is a NA study that has completed, run by UConn Health. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02667119, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the safety and efficacy of an integrated treatment for substance abuse and posttraumatic stress disorder for young adults. The integrated treatment includes two established psychosocial treatments for substance abuse (Contingency Management) and posttraumatic stress disorder (Prolonged Exposure therapy).
Primary Outcome
National Stressful Events Posttraumatic Stress Disorder Short Scale. Outcome is presented as a mean item score. Minimum value = 1, Maximum value = 5. Higher scores mean worse outcomes (more severe symptoms).
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Prolonged Exposure with Contingency Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
What the finished NCT02667119 record still lists
NCT02667119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02667119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02667119 about?
NCT02667119 is a clinical study titled "Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults". The purpose of the study is to determine the safety and efficacy of an integrated treatment for substance abuse and posttraumatic stress disorder for young adults. The integrated treatment includes two established psychosocial treatments for substance abuse (Contingency Management) and posttraumatic...
What is the current status of trial NCT02667119?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-04. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT02667119?
The interventions under investigation include: Standard Care (BEHAVIORAL), Prolonged Exposure with Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02667119?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02667119's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia